VERV logo

Verve Therapeutics, Inc. Common Stock


VERV: Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States.


Show VERV Financials

Consumer Interest
SEC Filings

Recent trades of VERV by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by VERV's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Compositions and methods for targeted rna delivery Dec. 28, 2021
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of VERV in WallStreetBets Daily Discussion


Recent insights relating to VERV

CNBC Recommendations

Recent picks made for VERV stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in VERV

Corporate Flights

Flights by private jets registered to VERV